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In this issue of the Biomedical Journal, we examine how far the explosion of epigenetic
studies in recent years has translated to benefits for patients in the clinic, and we highlight
an original study suggesting that increased vegetable intake protects against osteoporotic
fractures. We also hear several opinions on the use, or perhaps misuse, of Impact Factor
and what the future should hold for this publication metric.Spotlight on reviews
On the road to epigenetic therapy
The sequencing of the human genome at the turn of this
century heralded the exciting possibility that all complex
diseases could be understood by looking at DNA. This
excitement turned quickly into disappointment as genome-
wide association studies by and far failed to fulfil this ambi-
tious promise. Attention turned instead to the idea that the
mechanisms by which the book of DNA is read, and not the
book itself, might hold the answers. Recent years have seen
an explosion in studies investigating the role of such
“epigenetic” mechanisms in health and disease, but how far
has this work translated into benefits for patients? In this
issue of the Biomedical Journal, H€afner and Lund [1] explore
this question and conclude that the road ahead is still a long
and winding one.
Although initially coined in the 1940s by the embryologist
Conrad Waddington to describe the processes by which ge-
notype brings about phenotype [2], the term epigenetics hasg Gung University.
ublishing services by Else
s/by-nc-nd/4.0/).received a facelift in the modern era to encompass mecha-
nisms leading to functionally relevant changes in gene
expression that are not due tomodifications in DNA sequence.
As H€afner and Lund point out though, a consensus definition
of epigenetics is difficult to pin down, in particular with regard
to how stable such changes in gene expression must be and
the exact nature of the molecules involved. All sources agree
however that chemical modifications of DNA and histones
constitute epigenetic mechanisms [Fig. 1]. The histone pro-
teins that surround and compact our DNA are decorated with
post-translational modifications, such as acetylation and
methylation, which may recruit activating or repressive
complexes and determine the accessibility of underlying DNA.
Likewise the methylation of cytosine residues in DNA may
lead to transcriptional silencing at some genes and prevents
troublesome transposons from wreaking havoc on our DNA.
Ultimately, it is these mechanisms that enable the 200
different cell types of the human body to be produced from the
same genome.
Given their fundamental role in determining what genes
are expressed (and how much), it comes as no surprise that
alterations to these epigenetic modifications have beenvier B.V. This is an open access article under the CC BY-NC-ND
Fig. 1 e Epigenetic modifications and currently available treatments acting on them. Kindly provided by H€afner et al. [1], see
main article for more details.
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developmental disorders, cardiovascular disease and cancer
[3], with the latter being by far the best studied example.
Cancer cells typically show low levels of DNA methylation
coupled with pockets of hypermethylation at promoter re-
gions thatmay lead to the silencing of tumor suppressor genes
[4]. New sequencing technologies have recently identified
driver mutations in enzymes and proteins that establish,
erase or read epigenetic marks. The fact that epigenetic
modifications are reversible makes them highly promising
drug targets. A handful of epigenetic agents have been
approved by the US Food and Drug Administration, including
the DNA methylation inhibitor 5-azacytidine (Vidaza®) and
histone deacetylase inhibitors. These inhibitors have shown
some success in treating hematologicalmalignancies [5,6], but
suffer from the same drawbacks as many other chemothera-
peutic agents in that they act as a sledgehammer targeting
both cancerous and normal cells.
Enter the next generation of epigenetic inhibitors with
greater selectivity, which generally target reader, writer and
eraser proteins. Most are still in preclinical or early clinical
testing, and their optimal use will depend strongly on
knowledge of how exactly epigenetic pathways are disrupted
in cancer cells. For example, the histone lysine methylase
EZH2 is often overexpressed in cancer and is associated with
poor prognosis [7]. DNA sequencing has revealed a specificmutation in EZH2 in up to 22% of germinal center origin of
diffuse large B-cell lymphoma (DLBCL) [8]. In cellular assays,
the EZH2 inhibitor GSK126 strongly limits the growth of EZH2
mutant DLBCL cells but not EZH2 wild-type cells [9].
With the increasing accessibility of sequencing technolo-
gies and global efforts to catalogue epigenomes (take the
Human Epigenome Project for example), the possibility that
drugs can be developed to target particular epigenetic mech-
anisms gone haywire specifically in cancer cells becomes
foreseeable in the near future. Yet, as H€afner and Lund
conclude, such therapies are meant to be complementary to
and not replace existing treatments, and with an ever-
changing disease like cancer, “having more than one string
to one's bow won't be amiss”.Spotlight on original articles
Vegetables intake may protect against osteoporosis
We are all well aware of the health benefits of the mighty
vegetable. Both fruits and vegetables are rich sources of vita-
mins, minerals, dietary fiber and antioxidants. Low consump-
tion is linked to increased risk of non-communicable diseases,
with WHO estimating that 5.2 million deaths worldwide in
2013 were attributable to inadequate fruit and vegetable
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to be conducted in Taiwan, Lin et al. [11] potentially add a new
superpower to the effects of high vegetable consumption:
protection against osteoporotic fractures.
Osteoporosis causes bones to become brittle and weak,
such that a simple fall or even mild stress may lead to a
fracture. Postmenopausal women are at highest risk, with
nearly one third of such women in Europe, the US and
Taiwan developing the condition [12,13]. Modifiable risk fac-
tors have been linked to bone health including exercise [14]
although some studies do not support the link between
milk consumption and good bone health [15]). Some studies
have found a positive association between bone mineral
density and vegetable consumption [16,17], although few
prospective or longitudinal studies, particularly in Asian
countries where diets are very different from the Western
norm, have examined this link.
In this context, Lin et al. set out to investigate prospectively
the relationship between lifestyle factors and the incidence of
fall-related fractures in postmenopausal Taiwanese women.
They recruited female volunteers from a community health
clinic and performed blood samples, body measurements and
questionnaires inquiring about lifestyle factors such as weekly
diet. In total 953 women recruited responded to telephone in-
terviews in the 2 and ½ years following this initial analysis.
During this period, falls were reported by 183 women, 25 of
whom incurred fractures. Among women who reported a fall,
vegetable consumption was significantly lower in women
incurring a fracture, with the cut-off (i.e. the point atwhich this
effect was the strongest) being vegetable consumption <6
times a week. Other variables including milk consumption,
BMI and exercise had no obvious associationwith fracture risk.
These findings support the findings of previous (although
not all) studies that vegetable consumption decreases the risk
of fractures in postmenopausal women [18,19], although the
exact mechanism behind this effect is unclear. After dairy
products, vegetables are the second largest source of dietary
calcium in the Taiwanese population [20]. Reports in the lay e
often alternative health section e of the press argue that
vegetables are a superior source of calcium and even go as far
as renouncing milk as bone-weakening with claims that its
acid-producing properties raise blood pH leading to the
dissolution of bone. However, diet has little effect on systemic
pH [21], which is effectively managed by the kidneys. Thus,
the key to healthy bones probably lies in sufficient calcium
(and vitamin D) intake, regardless of source. Although these
findings await replication in a larger study, Lin et al. conclude
by recommending that individuals consume vegetables at
least twice per day for better bone health.Also in this issue:
Review articles
The central role of the neurosurgeon in epilepsy treatment
Epilepsy that does not respond to pharmacological treatment
can be effectively and safely treatment by surgery [22]. In this
review, Son and Kim [23] highlight the importance of the earlyand central involvement of the neurosurgeon in the man-
agement of such patients for optimal treatment.
The inflammasome: it's not all in the name
The inflammasome, as its name suggests, strongly initiates a
pro-inflammatory response when it senses pathogens and
cellular damage in innate immune cells. In this review
however, Martel et al. [24] discuss some of the lesser known
roles of the inflammasome in autophagy, metabolism, ei-
cosanoids production and phagosome maturation, and sug-
gest that it is about time that this “complex” complex was re-
baptized.
Original articles
New algorithm may predict benefits of weight loss in diabetics
Overweight and obesity account for a major proportion of
cases of diabetes mellitus (DM). Although the health benefits
of shedding excess pounds are clear, weight loss does not
enable all patients to reduce their dose of antidiabetic medi-
cation. In this retrospective study of 121 obese or overweight
patients with DM, Shantha et al. [25] devise the “WIG” scoring
system based on weight loss in the first 3 months of lifestyle
intervention, and markers of insulin resistance and blood
sugar control. The WIG system predicted with moderate ac-
curacy those patients able to achieve dose reductions
following weight loss and thus may prove a useful tool if
validated in a larger weight loss trial.
Risk factors and incidence of post-stroke depression in Taiwan
Post-stroke depression (PSD) is a serious complication that
occurs in around one third of stroke patients [26]. PSD strongly
impairs recovery after stroke, yet only a minority of patients
are diagnosed and treated in clinical practice [27]. Tsai et al.
[28] investigate the incidence of and risk factors associated
with PSD in stroke patients followed up for one year in a
Taiwanese hospital. Their findings highlight again that the
development of PSD is not only restricted to the initial months
after stroke, and identify female gender and high depressive
score at baseline as risk factors for the condition.
Cataloguing osteoarthritic changes of the jaw
Osteoarthritis (OA) is an age-related common chronic condi-
tion of the joints resulting from the breakdown of cartilage
and underlying bone. OA canmanifest in any joint, although it
primarily affects weight-bearing joints such as the knee and
hip. Mani et al. [29] use computer tomographic imaging to
investigate OA-related changes in elderly patients with
temporomandibular joint dysfunction and determine
whether they resemble changes seen in generalized OA. They
find that joint involvement, in particular condylar changes,
was very common in such patients and that most patients
were affected by early OA, hence advocating treatment at an
early stage to prevent disease progression.
Toothache is a major cause of emergency pediatric dental visits
in Taiwan
Little is known about the prevalence and cause of emergency
pediatric dental visits in Taiwan. To address this issue, Jung
et al. [30] search medical records from the largest hospital in
b i om e d i c a l j o u r n a l 3 9 ( 2 0 1 6 ) 1 6 1e1 6 5164Taiwan Pediatric dental emergencies over a two year period.
Although the most common cause for visits was orodental
trauma, 30% of visits were related to toothache, suggesting
that raising awareness about proper at-home care could
reduce the number of emergency visits.
Correspondence
Psychobiotics: the dawn of bacterial-based mood enhancers?
Perhaps the road to happiness lies in ingesting the right bac-
teria? In this correspondence, Kali [31] discusses the emerging
field of psychobiotics, defined as living organisms that pro-
duce a health benefit in patients with psychiatric disorders
when ingested in adequate amounts.
Letter
Should we revise or simply forget Impact Factor?
Recent issues of the Biomedical Journal included an article [32]
and its subsequent letter [33] relating to the problems with
Impact Factor. Mention of this publication metric stirs strong
emotions within the scientific community, exemplified
perhaps in three contrasting opinions about the use of Impact
Factor published as letters in this issue. Many suggestions
have been proposed to improve the metric in the past. Shan-
bag [34] argues that banning self-citation and restricting the
total number of citations does not make sense because
imposing such rules could limit the citation of good quality
articles. Padubidri and Shetty [35] on the other hand argue
that self-citation is a source of great bias, and that a correction
factor could be introduced to limit the number of self-citations
in a particular journal. Finally, Kanchan and Krishan [36] think
instead that trying to quantify quality is an almost futile ex-
ercise. In their view, the problemwith Impact Factor lies not in
the index itself but in its inappropriate use. Impact Factor,
they conclude, has been taken out of context and should be
used judiciously when deciding on grant allocations and
career promotion.r e f e r e n c e s
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